

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07491785 |
| 2 | regulation of cholesterol esterification (GO:0010872) | 4.04679250 |
| 3 | histone H3-K36 demethylation (GO:0070544) | 4.03242390 |
| 4 | nuclear pore complex assembly (GO:0051292) | 3.98793103 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81258682 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81258682 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68841668 |
| 8 | nuclear pore organization (GO:0006999) | 3.67622134 |
| 9 | regulation of histone H3-K27 methylation (GO:0061085) | 3.63753339 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49567634 |
| 11 | thymic T cell selection (GO:0045061) | 3.47451584 |
| 12 | regulation of RNA export from nucleus (GO:0046831) | 3.45207940 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.45088974 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37607735 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 3.35531752 |
| 16 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.35461158 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.34302761 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34302761 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.32482711 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.27948685 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.27948685 |
| 22 | tryptophan catabolic process (GO:0006569) | 3.27948685 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 3.27605990 |
| 24 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.27003865 |
| 25 | T cell selection (GO:0045058) | 3.22911486 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21918805 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 3.20132697 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.20132697 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.18937812 |
| 30 | complement activation, alternative pathway (GO:0006957) | 3.18665370 |
| 31 | urea cycle (GO:0000050) | 3.15381989 |
| 32 | urea metabolic process (GO:0019627) | 3.15381989 |
| 33 | protein localization to endosome (GO:0036010) | 3.13832419 |
| 34 | growth hormone receptor signaling pathway (GO:0060396) | 3.11012494 |
| 35 | phospholipid efflux (GO:0033700) | 3.09414750 |
| 36 | positive T cell selection (GO:0043368) | 3.04936069 |
| 37 | hypotonic response (GO:0006971) | 3.04532135 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.03617629 |
| 39 | leukocyte aggregation (GO:0070486) | 3.02857017 |
| 40 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.00775195 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.00308007 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98706365 |
| 43 | valine metabolic process (GO:0006573) | 2.96976986 |
| 44 | activation of Rac GTPase activity (GO:0032863) | 2.95463219 |
| 45 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.94117028 |
| 46 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.93923470 |
| 47 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.91444084 |
| 48 | L-phenylalanine metabolic process (GO:0006558) | 2.90711553 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.90711553 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.89383116 |
| 51 | RNA stabilization (GO:0043489) | 2.85404851 |
| 52 | mRNA stabilization (GO:0048255) | 2.85404851 |
| 53 | regulation of chromatin binding (GO:0035561) | 2.85088217 |
| 54 | histone H3-K4 trimethylation (GO:0080182) | 2.84653638 |
| 55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84574738 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84294902 |
| 57 | response to muramyl dipeptide (GO:0032495) | 2.82838796 |
| 58 | histone lysine demethylation (GO:0070076) | 2.82762162 |
| 59 | hepatocyte apoptotic process (GO:0097284) | 2.82454429 |
| 60 | bile acid biosynthetic process (GO:0006699) | 2.82223034 |
| 61 | cell-substrate adherens junction assembly (GO:0007045) | 2.80626499 |
| 62 | focal adhesion assembly (GO:0048041) | 2.80626499 |
| 63 | glutamate metabolic process (GO:0006536) | 2.80346271 |
| 64 | phospholipid homeostasis (GO:0055091) | 2.78177113 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76972193 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.76972193 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76972193 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76972193 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76972193 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.76972193 |
| 71 | negative thymic T cell selection (GO:0045060) | 2.76964289 |
| 72 | reverse cholesterol transport (GO:0043691) | 2.76047177 |
| 73 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.75431146 |
| 74 | negative T cell selection (GO:0043383) | 2.74896859 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 2.73505252 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73306173 |
| 77 | histone H3-K9 demethylation (GO:0033169) | 2.72805327 |
| 78 | mitotic chromosome condensation (GO:0007076) | 2.72579103 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.72141246 |
| 80 | pore complex assembly (GO:0046931) | 2.72018160 |
| 81 | detection of other organism (GO:0098543) | 2.71631228 |
| 82 | regulation of protein activation cascade (GO:2000257) | 2.70300686 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 2.69877643 |
| 84 | protein localization to microtubule (GO:0035372) | 2.69075579 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.69072036 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 2.68260305 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 2.67195588 |
| 88 | positive regulation of respiratory burst (GO:0060267) | 2.66556426 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 2.65546591 |
| 90 | macromolecular complex remodeling (GO:0034367) | 2.65546591 |
| 91 | plasma lipoprotein particle remodeling (GO:0034369) | 2.65546591 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.64553592 |
| 93 | T-helper cell differentiation (GO:0042093) | 2.64553592 |
| 94 | detection of bacterium (GO:0016045) | 2.64523447 |
| 95 | histone demethylation (GO:0016577) | 2.63485774 |
| 96 | maternal placenta development (GO:0001893) | 2.63100381 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 2.62484411 |
| 98 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.61606417 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61155043 |
| 100 | cellular response to growth hormone stimulus (GO:0071378) | 2.60975286 |
| 101 | peptidyl-threonine modification (GO:0018210) | 2.59721893 |
| 102 | protein carboxylation (GO:0018214) | 2.59684465 |
| 103 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.59684465 |
| 104 | embryonic process involved in female pregnancy (GO:0060136) | 2.59466585 |
| 105 | regulation of defense response to virus by virus (GO:0050690) | 2.58987510 |
| 106 | peptidyl-threonine phosphorylation (GO:0018107) | 2.57730940 |
| 107 | cellular glucuronidation (GO:0052695) | 2.56936325 |
| 108 | negative regulation of histone methylation (GO:0031061) | 2.56570856 |
| 109 | lysine catabolic process (GO:0006554) | 2.55688422 |
| 110 | lysine metabolic process (GO:0006553) | 2.55688422 |
| 111 | negative regulation of T cell mediated immunity (GO:0002710) | 2.54809709 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54522930 |
| 113 | regulation of complement activation (GO:0030449) | 2.53670889 |
| 114 | adherens junction assembly (GO:0034333) | 2.53323643 |
| 115 | mitotic sister chromatid cohesion (GO:0007064) | 2.51599965 |
| 116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.51103720 |
| 117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.49482806 |
| 118 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49201608 |
| 119 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.49070034 |
| 120 | dosage compensation (GO:0007549) | 2.49049075 |
| 121 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48616068 |
| 122 | negative regulation of cholesterol transport (GO:0032375) | 2.48006413 |
| 123 | negative regulation of sterol transport (GO:0032372) | 2.48006413 |
| 124 | cysteine metabolic process (GO:0006534) | 2.46535431 |
| 125 | DNA unwinding involved in DNA replication (GO:0006268) | 2.44899249 |
| 126 | B cell homeostasis (GO:0001782) | 2.44811043 |
| 127 | plasma lipoprotein particle clearance (GO:0034381) | 2.44113739 |
| 128 | regulation of cholesterol transport (GO:0032374) | 2.43072086 |
| 129 | regulation of sterol transport (GO:0032371) | 2.43072086 |
| 130 | regulation of B cell differentiation (GO:0045577) | 2.42492033 |
| 131 | negative regulation of fibrinolysis (GO:0051918) | 2.42489770 |
| 132 | glyoxylate metabolic process (GO:0046487) | 2.42365139 |
| 133 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.41581810 |
| 134 | bile acid metabolic process (GO:0008206) | 2.40910349 |
| 135 | cholesterol efflux (GO:0033344) | 2.40791701 |
| 136 | cell-substrate junction assembly (GO:0007044) | 2.39321946 |
| 137 | germinal center formation (GO:0002467) | 2.39182372 |
| 138 | cellular response to interleukin-15 (GO:0071350) | 2.38926526 |
| 139 | activation of JUN kinase activity (GO:0007257) | 2.38392222 |
| 140 | regulation of hypersensitivity (GO:0002883) | 2.38177812 |
| 141 | cellular modified amino acid catabolic process (GO:0042219) | 2.37993419 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37380019 |
| 143 | T cell homeostasis (GO:0043029) | 2.37348561 |
| 144 | negative regulation of histone modification (GO:0031057) | 2.36747653 |
| 145 | mammary gland epithelial cell proliferation (GO:0033598) | 2.36281342 |
| 146 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.36280536 |
| 147 | histone H4-K16 acetylation (GO:0043984) | 2.34631830 |
| 148 | corticosteroid receptor signaling pathway (GO:0031958) | 2.34558172 |
| 149 | regulation of water loss via skin (GO:0033561) | 2.33782153 |
| 150 | triglyceride homeostasis (GO:0070328) | 2.33735997 |
| 151 | acylglycerol homeostasis (GO:0055090) | 2.33735997 |
| 152 | homocysteine metabolic process (GO:0050667) | 2.33723925 |
| 153 | protein export from nucleus (GO:0006611) | 2.33538106 |
| 154 | tolerance induction (GO:0002507) | 2.33487372 |
| 155 | modulation by symbiont of host cellular process (GO:0044068) | 2.33052461 |
| 156 | histone H3-K4 methylation (GO:0051568) | 2.32794988 |
| 157 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.31944616 |
| 158 | regulation of cholesterol homeostasis (GO:2000188) | 2.31746030 |
| 159 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.31227245 |
| 160 | trophectodermal cell differentiation (GO:0001829) | 2.30998958 |
| 161 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.30811471 |
| 162 | regulation of fibrinolysis (GO:0051917) | 2.30242120 |
| 163 | regulation of necroptotic process (GO:0060544) | 2.29640093 |
| 164 | sulfur amino acid catabolic process (GO:0000098) | 2.29249188 |
| 165 | protein dealkylation (GO:0008214) | 2.28094943 |
| 166 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.26883858 |
| 167 | cytolysis (GO:0019835) | 2.26146225 |
| 168 | fatty acid transmembrane transport (GO:1902001) | 2.26008377 |
| 169 | response to interleukin-15 (GO:0070672) | 2.25860890 |
| 170 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.22763089 |
| 171 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.22763089 |
| 172 | T cell differentiation involved in immune response (GO:0002292) | 2.22763089 |
| 173 | regulation of cholesterol storage (GO:0010885) | 2.20441007 |
| 174 | cellular ketone body metabolic process (GO:0046950) | 2.18315207 |
| 175 | amino-acid betaine metabolic process (GO:0006577) | 2.18152631 |
| 176 | negative regulation of lipase activity (GO:0060192) | 2.17869085 |
| 177 | acute-phase response (GO:0006953) | 2.17739547 |
| 178 | positive regulation of fatty acid oxidation (GO:0046321) | 2.17513857 |
| 179 | low-density lipoprotein particle remodeling (GO:0034374) | 2.17075630 |
| 180 | plasma lipoprotein particle organization (GO:0071827) | 2.15823713 |
| 181 | positive regulation of cholesterol transport (GO:0032376) | 2.15778259 |
| 182 | positive regulation of sterol transport (GO:0032373) | 2.15778259 |
| 183 | mature B cell differentiation (GO:0002335) | 2.14776645 |
| 184 | interferon-gamma production (GO:0032609) | 2.14545194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51549109 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.97433536 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70097559 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.55967184 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.45024513 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.19681773 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17780275 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.90776583 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.80678370 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76971671 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67233522 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49523208 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48726701 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34453392 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27962717 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.26568989 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.15675172 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.07410145 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02235545 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00860652 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00582161 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99164913 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97495348 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97145492 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.93351045 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88162384 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84236941 |
| 28 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79258119 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73800862 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73744091 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70743555 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67945927 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66256208 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65065035 |
| 35 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.63618765 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.62374954 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60705107 |
| 38 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.57717430 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57184486 |
| 40 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.57083556 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56587435 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56135155 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55631099 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52105827 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49631647 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45845148 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43272929 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39729648 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39326185 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39071733 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36940825 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36346658 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35824098 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35536010 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35329134 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34755969 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.33339163 |
| 58 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32815616 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32640317 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30619349 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29486754 |
| 62 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.28659958 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28606548 |
| 64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28298380 |
| 65 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27445036 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.25975541 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25534015 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25270377 |
| 69 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25083806 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24953104 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23176949 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23154785 |
| 73 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21571264 |
| 74 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21571264 |
| 75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19521677 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19366656 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19097389 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18163642 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17602525 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16796130 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16473961 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16453202 |
| 83 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16132973 |
| 84 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.15673430 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14440116 |
| 86 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13869543 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13020109 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12778361 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11785576 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11697869 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10883276 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10336848 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10101158 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07959428 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06475073 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06007220 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05832109 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05724091 |
| 99 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04980727 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04352011 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03665721 |
| 102 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03341581 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02624288 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02500438 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01874796 |
| 106 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01689995 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01228243 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00666025 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00045413 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99558001 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99530477 |
| 112 | MYC_22102868_ChIP-Seq_BL_Human | 0.99161325 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98950972 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98354643 |
| 115 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97981775 |
| 116 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97969062 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97236168 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97017862 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96766087 |
| 120 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96544485 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95782991 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94982983 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94317128 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94285622 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94285622 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93647923 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93195232 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92091748 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91715077 |
| 130 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90372790 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89761998 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87631864 |
| 133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87430640 |
| 134 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87252910 |
| 135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87157263 |
| 136 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87039245 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86669894 |
| 138 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84693349 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83920084 |
| 140 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82551076 |
| 141 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81706441 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80387767 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80208778 |
| 144 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80144171 |
| 145 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.79723991 |
| 146 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79455338 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78580920 |
| 148 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77266538 |
| 149 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76434533 |
| 150 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76408332 |
| 151 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76317401 |
| 152 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75979014 |
| 153 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75979014 |
| 154 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75634463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.72565871 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.64539978 |
| 3 | MP0005365_abnormal_bile_salt | 3.14426019 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.97482740 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.89879689 |
| 6 | MP0008057_abnormal_DNA_replication | 2.89156863 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.84886599 |
| 8 | MP0000685_abnormal_immune_system | 2.73976683 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.68392577 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.62425905 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.58919454 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.57235957 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.50725913 |
| 14 | MP0002009_preneoplasia | 2.46601127 |
| 15 | MP0002254_reproductive_system_inflammat | 2.33893202 |
| 16 | MP0005451_abnormal_body_composition | 2.22921484 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.20234894 |
| 18 | MP0003252_abnormal_bile_duct | 2.14807729 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.13238446 |
| 20 | MP0005409_darkened_coat_color | 2.11637318 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.11049700 |
| 22 | MP0003436_decreased_susceptibility_to | 2.07928905 |
| 23 | MP0005387_immune_system_phenotype | 2.05067728 |
| 24 | MP0001790_abnormal_immune_system | 2.05067728 |
| 25 | MP0002006_tumorigenesis | 2.02328090 |
| 26 | MP0004130_abnormal_muscle_cell | 1.96191186 |
| 27 | MP0003303_peritoneal_inflammation | 1.93454477 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.91829328 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.88992188 |
| 30 | MP0003091_abnormal_cell_migration | 1.87595889 |
| 31 | MP0005671_abnormal_response_to | 1.86572665 |
| 32 | MP0004381_abnormal_hair_follicle | 1.84783619 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.78188805 |
| 34 | MP0001800_abnormal_humoral_immune | 1.76891472 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.74241296 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.73783497 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.72810613 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.72545075 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.70759689 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.68477993 |
| 41 | MP0004947_skin_inflammation | 1.67591059 |
| 42 | MP0000604_amyloidosis | 1.65370533 |
| 43 | MP0004510_myositis | 1.63768298 |
| 44 | MP0005501_abnormal_skin_physiology | 1.61753955 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.60923237 |
| 46 | MP0004233_abnormal_muscle_weight | 1.60233082 |
| 47 | MP0004264_abnormal_extraembryonic_tissu | 1.50862736 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.50251414 |
| 49 | MP0002723_abnormal_immune_serum | 1.46461024 |
| 50 | MP0002419_abnormal_innate_immunity | 1.45746397 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.45619441 |
| 52 | MP0000609_abnormal_liver_physiology | 1.45182641 |
| 53 | MP0005332_abnormal_amino_acid | 1.44879753 |
| 54 | MP0009785_altered_susceptibility_to | 1.43939904 |
| 55 | MP0005025_abnormal_response_to | 1.42898615 |
| 56 | MP0008260_abnormal_autophagy | 1.42774833 |
| 57 | MP0004859_abnormal_synaptic_plasticity | 1.34907976 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.34450746 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.33289325 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.32672907 |
| 61 | MP0000733_abnormal_muscle_development | 1.31911566 |
| 62 | MP0001819_abnormal_immune_cell | 1.30181505 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.29993036 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.29935819 |
| 65 | MP0001216_abnormal_epidermal_layer | 1.28732095 |
| 66 | MP0009840_abnormal_foam_cell | 1.27163796 |
| 67 | MP0009764_decreased_sensitivity_to | 1.25942406 |
| 68 | MP0006082_CNS_inflammation | 1.25399567 |
| 69 | MP0001873_stomach_inflammation | 1.24108784 |
| 70 | MP0000858_altered_metastatic_potential | 1.23958647 |
| 71 | MP0001730_embryonic_growth_arrest | 1.23635058 |
| 72 | MP0001853_heart_inflammation | 1.22351606 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21961986 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.19701798 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.18208245 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.16106644 |
| 77 | MP0005621_abnormal_cell_physiology | 1.13171133 |
| 78 | MP0005535_abnormal_body_temperature | 1.12713259 |
| 79 | MP0000350_abnormal_cell_proliferation | 1.12678383 |
| 80 | MP0005310_abnormal_salivary_gland | 1.11158876 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.11069992 |
| 82 | MP0000377_abnormal_hair_follicle | 1.10810203 |
| 83 | MP0000490_abnormal_crypts_of | 1.09729690 |
| 84 | MP0008469_abnormal_protein_level | 1.09682848 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.07628640 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.06789007 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 1.06541455 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.05817460 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.03102187 |
| 90 | MP0002060_abnormal_skin_morphology | 1.02523303 |
| 91 | MP0001851_eye_inflammation | 1.02005045 |
| 92 | MP0003868_abnormal_feces_composition | 1.01690899 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 1.01485477 |
| 94 | MP0000579_abnormal_nail_morphology | 1.01017607 |
| 95 | MP0000716_abnormal_immune_system | 0.99954323 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.99571178 |
| 97 | MP0003329_amyloid_beta_deposits | 0.99462451 |
| 98 | MP0002398_abnormal_bone_marrow | 0.99111651 |
| 99 | MP0005083_abnormal_biliary_tract | 0.97245508 |
| 100 | MP0002971_abnormal_brown_adipose | 0.95419347 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.95392314 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.94271720 |
| 103 | MP0003111_abnormal_nucleus_morphology | 0.94017978 |
| 104 | MP0001849_ear_inflammation | 0.93787026 |
| 105 | MP0009931_abnormal_skin_appearance | 0.92663185 |
| 106 | MP0009278_abnormal_bone_marrow | 0.90607829 |
| 107 | MP0003075_altered_response_to | 0.90136462 |
| 108 | MP0009672_abnormal_birth_weight | 0.90071132 |
| 109 | MP0002086_abnormal_extraembryonic_tissu | 0.89917569 |
| 110 | MP0005166_decreased_susceptibility_to | 0.89664234 |
| 111 | MP0010307_abnormal_tumor_latency | 0.87636596 |
| 112 | MP0003045_fibrosis | 0.86845859 |
| 113 | MP0003077_abnormal_cell_cycle | 0.86469826 |
| 114 | MP0009763_increased_sensitivity_to | 0.85860688 |
| 115 | MP0003984_embryonic_growth_retardation | 0.85477451 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.85290819 |
| 117 | MP0003828_pulmonary_edema | 0.85230331 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.84992412 |
| 119 | MP0005380_embryogenesis_phenotype | 0.84992412 |
| 120 | MP0003690_abnormal_glial_cell | 0.83610257 |
| 121 | MP0002088_abnormal_embryonic_growth/wei | 0.83195788 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.80282299 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.79550494 |
| 124 | MP0002796_impaired_skin_barrier | 0.77881335 |
| 125 | MP0003866_abnormal_defecation | 0.77456910 |
| 126 | MP0003195_calcinosis | 0.77159256 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.76891806 |
| 128 | MP0000627_abnormal_mammary_gland | 0.76561011 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76376514 |
| 130 | MP0008874_decreased_physiological_sensi | 0.75866698 |
| 131 | MP0005334_abnormal_fat_pad | 0.75760038 |
| 132 | MP0005647_abnormal_sex_gland | 0.75616023 |
| 133 | MP0003633_abnormal_nervous_system | 0.75606504 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.75529554 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.75242010 |
| 136 | MP0000678_abnormal_parathyroid_gland | 0.74718607 |
| 137 | MP0005023_abnormal_wound_healing | 0.73615752 |
| 138 | MP0002722_abnormal_immune_system | 0.72978864 |
| 139 | MP0002405_respiratory_system_inflammati | 0.71464101 |
| 140 | MP0005275_abnormal_skin_tensile | 0.70545843 |
| 141 | MP0002429_abnormal_blood_cell | 0.70448034 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.70442788 |
| 143 | MP0005384_cellular_phenotype | 0.70231293 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.70119933 |
| 145 | MP0002080_prenatal_lethality | 0.69513448 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.69038412 |
| 147 | MP0004957_abnormal_blastocyst_morpholog | 0.68962108 |
| 148 | MP0005174_abnormal_tail_pigmentation | 0.68832285 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.68532780 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.68087032 |
| 151 | MP0002822_catalepsy | 0.67261679 |
| 152 | MP0001915_intracranial_hemorrhage | 0.67152371 |
| 153 | MP0003635_abnormal_synaptic_transmissio | 0.67141256 |
| 154 | MP0009745_abnormal_behavioral_response | 0.67090677 |
| 155 | MP0005375_adipose_tissue_phenotype | 0.65663236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 4.54253795 |
| 2 | Deep venous thrombosis (HP:0002625) | 3.75778253 |
| 3 | Xanthomatosis (HP:0000991) | 3.32827800 |
| 4 | Myocardial infarction (HP:0001658) | 3.20942505 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08699598 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.02347301 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 2.99574340 |
| 8 | Complement deficiency (HP:0004431) | 2.99235575 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96411780 |
| 10 | Epidermoid cyst (HP:0200040) | 2.89750920 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89274986 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 2.74351804 |
| 13 | Broad face (HP:0000283) | 2.68266652 |
| 14 | Obstructive sleep apnea (HP:0002870) | 2.65118439 |
| 15 | Syringomyelia (HP:0003396) | 2.62812202 |
| 16 | Spinal cord lesions (HP:0100561) | 2.62812202 |
| 17 | Gingival bleeding (HP:0000225) | 2.60749985 |
| 18 | Ankyloglossia (HP:0010296) | 2.59173343 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56981669 |
| 20 | Cellulitis (HP:0100658) | 2.52322720 |
| 21 | Viral hepatitis (HP:0006562) | 2.48415201 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47873794 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.45593384 |
| 24 | Flat acetabular roof (HP:0003180) | 2.44420080 |
| 25 | Mitral stenosis (HP:0001718) | 2.44037605 |
| 26 | Abnormality of the fingertips (HP:0001211) | 2.42740980 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 2.41717047 |
| 28 | Joint hemorrhage (HP:0005261) | 2.41582451 |
| 29 | Abnormality of complement system (HP:0005339) | 2.35831754 |
| 30 | Hyperacusis (HP:0010780) | 2.35156575 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.32936961 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.32820673 |
| 33 | Heterotopia (HP:0002282) | 2.32266279 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32166372 |
| 35 | Arterial thrombosis (HP:0004420) | 2.30024564 |
| 36 | Asymmetry of the thorax (HP:0001555) | 2.27567671 |
| 37 | Recurrent viral infections (HP:0004429) | 2.26042960 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.24516768 |
| 39 | Abnormality of oral frenula (HP:0000190) | 2.24342945 |
| 40 | Disinhibition (HP:0000734) | 2.22281000 |
| 41 | Selective tooth agenesis (HP:0001592) | 2.21990350 |
| 42 | Verrucae (HP:0200043) | 2.20831482 |
| 43 | Papilloma (HP:0012740) | 2.20831482 |
| 44 | Entropion (HP:0000621) | 2.20268231 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.19776195 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.18662377 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.17979718 |
| 48 | Hematochezia (HP:0002573) | 2.17071261 |
| 49 | Increased IgE level (HP:0003212) | 2.16451692 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.14641493 |
| 51 | Impaired social interactions (HP:0000735) | 2.13451825 |
| 52 | Abnormal social behavior (HP:0012433) | 2.13451825 |
| 53 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.12260331 |
| 54 | Conjunctival hamartoma (HP:0100780) | 2.11625348 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 2.11499410 |
| 56 | Skin nodule (HP:0200036) | 2.10783625 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.09769283 |
| 58 | Dysmetric saccades (HP:0000641) | 2.09626917 |
| 59 | Ketosis (HP:0001946) | 2.09157756 |
| 60 | Germ cell neoplasia (HP:0100728) | 2.08215342 |
| 61 | Arterial tortuosity (HP:0005116) | 2.07723724 |
| 62 | Osteolytic defects of the hand bones (HP:0009699) | 2.07203964 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.07203964 |
| 64 | Deep palmar crease (HP:0006191) | 2.05082132 |
| 65 | Neonatal hypoglycemia (HP:0001998) | 2.03948669 |
| 66 | Abnormality of nail color (HP:0100643) | 2.03654423 |
| 67 | Dislocated radial head (HP:0003083) | 2.03113588 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02729928 |
| 69 | Recurrent skin infections (HP:0001581) | 2.02120159 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02091234 |
| 71 | Long palpebral fissure (HP:0000637) | 2.01154629 |
| 72 | Pulmonary embolism (HP:0002204) | 2.00939212 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98868243 |
| 74 | Myositis (HP:0100614) | 1.98866348 |
| 75 | Thrombophlebitis (HP:0004418) | 1.97412105 |
| 76 | Spontaneous abortion (HP:0005268) | 1.96580396 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 1.96425283 |
| 78 | Hypoglycemic coma (HP:0001325) | 1.95535697 |
| 79 | Agammaglobulinemia (HP:0004432) | 1.95428198 |
| 80 | Poor eye contact (HP:0000817) | 1.95390744 |
| 81 | Thin bony cortex (HP:0002753) | 1.95240338 |
| 82 | Dilatation of the ascending aorta (HP:0005111) | 1.94326061 |
| 83 | Milia (HP:0001056) | 1.94285226 |
| 84 | Chronic otitis media (HP:0000389) | 1.93220513 |
| 85 | Macroorchidism (HP:0000053) | 1.93191771 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 1.92676038 |
| 87 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91825975 |
| 88 | Abnormality of the radial head (HP:0003995) | 1.91280161 |
| 89 | Micronodular cirrhosis (HP:0001413) | 1.90974508 |
| 90 | Acanthocytosis (HP:0001927) | 1.90356162 |
| 91 | Colitis (HP:0002583) | 1.89872514 |
| 92 | Sparse lateral eyebrow (HP:0005338) | 1.89507129 |
| 93 | Poikiloderma (HP:0001029) | 1.88919829 |
| 94 | Fatigue (HP:0012378) | 1.87923356 |
| 95 | Amyloidosis (HP:0011034) | 1.87468170 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.87173312 |
| 97 | Polycythemia (HP:0001901) | 1.86220616 |
| 98 | Inflammation of the large intestine (HP:0002037) | 1.85413230 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 1.84638882 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84637694 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84637694 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 1.84454278 |
| 103 | Subaortic stenosis (HP:0001682) | 1.84216874 |
| 104 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84216874 |
| 105 | Inappropriate behavior (HP:0000719) | 1.83557941 |
| 106 | Distal lower limb amyotrophy (HP:0008944) | 1.83274454 |
| 107 | Lip pit (HP:0100267) | 1.83008950 |
| 108 | Vasculitis (HP:0002633) | 1.79968630 |
| 109 | Deep philtrum (HP:0002002) | 1.79911794 |
| 110 | Persistence of primary teeth (HP:0006335) | 1.79896912 |
| 111 | Lower limb hyperreflexia (HP:0002395) | 1.79888359 |
| 112 | Vascular tortuosity (HP:0004948) | 1.79825265 |
| 113 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79741951 |
| 114 | Epistaxis (HP:0000421) | 1.79596138 |
| 115 | Death in childhood (HP:0003819) | 1.79061253 |
| 116 | Joint swelling (HP:0001386) | 1.78806501 |
| 117 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78668113 |
| 118 | Hypercholesterolemia (HP:0003124) | 1.78542248 |
| 119 | Osteomyelitis (HP:0002754) | 1.77877835 |
| 120 | Basal cell carcinoma (HP:0002671) | 1.77212015 |
| 121 | Cubitus valgus (HP:0002967) | 1.75908114 |
| 122 | Cerebral hemorrhage (HP:0001342) | 1.75840102 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.75555459 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.75411616 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.75411616 |
| 126 | Retrobulbar optic neuritis (HP:0100654) | 1.74946574 |
| 127 | Optic neuritis (HP:0100653) | 1.74946574 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.74516370 |
| 129 | Gingivitis (HP:0000230) | 1.73987600 |
| 130 | Hyperammonemia (HP:0001987) | 1.73949895 |
| 131 | Orchitis (HP:0100796) | 1.73414475 |
| 132 | Slow saccadic eye movements (HP:0000514) | 1.73403097 |
| 133 | Pulmonary infiltrates (HP:0002113) | 1.72998102 |
| 134 | Fat malabsorption (HP:0002630) | 1.71885534 |
| 135 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71763458 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.71709861 |
| 137 | Mitral valve prolapse (HP:0001634) | 1.71673691 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.71611088 |
| 139 | Absent frontal sinuses (HP:0002688) | 1.71306106 |
| 140 | Subacute progressive viral hepatitis (HP:0006572) | 1.71079341 |
| 141 | Urticaria (HP:0001025) | 1.70964319 |
| 142 | Periodontitis (HP:0000704) | 1.70779109 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 1.69702507 |
| 144 | Frequent falls (HP:0002359) | 1.69623117 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.69308114 |
| 146 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.68638786 |
| 147 | Meningitis (HP:0001287) | 1.67671895 |
| 148 | Vertebral arch anomaly (HP:0008438) | 1.67527194 |
| 149 | Neonatal onset (HP:0003623) | 1.67485874 |
| 150 | Coarse hair (HP:0002208) | 1.66986769 |
| 151 | Septate vagina (HP:0001153) | 1.66841337 |
| 152 | Hemiplegia (HP:0002301) | 1.66652312 |
| 153 | Long eyelashes (HP:0000527) | 1.66097306 |
| 154 | Hypoplasia of the thymus (HP:0000778) | 1.65895410 |
| 155 | T lymphocytopenia (HP:0005403) | 1.65862949 |
| 156 | Thick nail (HP:0001805) | 1.65431580 |
| 157 | Abnormality of the salivary glands (HP:0010286) | 1.64088153 |
| 158 | Ridged nail (HP:0001807) | 1.64026981 |
| 159 | Sandal gap (HP:0001852) | 1.62206947 |
| 160 | Short nail (HP:0001799) | 1.60523732 |
| 161 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.59553304 |
| 162 | Panhypogammaglobulinemia (HP:0003139) | 1.58993681 |
| 163 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.58445016 |
| 164 | Abnormal foot bone ossification (HP:0010675) | 1.58063496 |
| 165 | Abnormality of the columella (HP:0009929) | 1.57870091 |
| 166 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.57329167 |
| 167 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.57243781 |
| 168 | Chest pain (HP:0100749) | 1.56684044 |
| 169 | Bladder neoplasm (HP:0009725) | 1.56308860 |
| 170 | Bladder carcinoma (HP:0002862) | 1.56308860 |
| 171 | Deviation of the thumb (HP:0009603) | 1.54011564 |
| 172 | Ulnar bowing (HP:0003031) | 1.54010284 |
| 173 | Renal cell carcinoma (HP:0005584) | 1.53319742 |
| 174 | Uterine leiomyosarcoma (HP:0002891) | 1.52439474 |
| 175 | Leiomyosarcoma (HP:0100243) | 1.52439474 |
| 176 | Abnormality of chromosome segregation (HP:0002916) | 1.51569976 |
| 177 | Disproportionate tall stature (HP:0001519) | 1.50743104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.43790145 |
| 2 | CDK12 | 3.49080051 |
| 3 | TRIB3 | 2.90158095 |
| 4 | SMG1 | 2.87305658 |
| 5 | MAP3K14 | 2.74956610 |
| 6 | RIPK4 | 2.52859759 |
| 7 | MAP4K1 | 2.44345527 |
| 8 | MAP3K13 | 2.23442647 |
| 9 | ICK | 2.05996725 |
| 10 | FGFR4 | 2.05434708 |
| 11 | JAK1 | 2.03532054 |
| 12 | PKN2 | 2.03252189 |
| 13 | FRK | 2.02213362 |
| 14 | JAK3 | 1.96683222 |
| 15 | TYK2 | 1.94073123 |
| 16 | FGFR3 | 1.91174615 |
| 17 | SIK1 | 1.78127308 |
| 18 | RIPK1 | 1.67898350 |
| 19 | MAP3K7 | 1.56676899 |
| 20 | FGFR2 | 1.52762523 |
| 21 | TXK | 1.51862247 |
| 22 | TBK1 | 1.51822709 |
| 23 | GRK6 | 1.48651847 |
| 24 | IRAK2 | 1.47963494 |
| 25 | SYK | 1.45359293 |
| 26 | MAP2K4 | 1.44900482 |
| 27 | BRD4 | 1.43361767 |
| 28 | CSF1R | 1.41439081 |
| 29 | JAK2 | 1.39556732 |
| 30 | FLT3 | 1.37649206 |
| 31 | ERN1 | 1.37381318 |
| 32 | SIK2 | 1.36955812 |
| 33 | TTN | 1.36808764 |
| 34 | CDK6 | 1.35981999 |
| 35 | CAMKK1 | 1.35941604 |
| 36 | ZAP70 | 1.35878193 |
| 37 | DAPK2 | 1.34745477 |
| 38 | MAP2K3 | 1.33767194 |
| 39 | EPHA4 | 1.30909160 |
| 40 | IRAK3 | 1.27302815 |
| 41 | PDK1 | 1.19357172 |
| 42 | PDGFRA | 1.16909533 |
| 43 | RET | 1.16653251 |
| 44 | SIK3 | 1.14053199 |
| 45 | TNK2 | 1.13421615 |
| 46 | FES | 1.13120036 |
| 47 | TAOK3 | 1.11647168 |
| 48 | IKBKE | 1.09656184 |
| 49 | SCYL2 | 1.08750922 |
| 50 | IRAK4 | 1.07918298 |
| 51 | RPS6KB2 | 1.04607980 |
| 52 | NTRK3 | 1.04489730 |
| 53 | CDK9 | 1.02108009 |
| 54 | MAP3K10 | 1.01441580 |
| 55 | MARK2 | 1.01089917 |
| 56 | ITK | 1.01042132 |
| 57 | IKBKB | 1.00989256 |
| 58 | TGFBR2 | 1.00584613 |
| 59 | MTOR | 1.00418220 |
| 60 | KIT | 0.99521666 |
| 61 | INSRR | 0.99254004 |
| 62 | SGK3 | 0.97091027 |
| 63 | PTK6 | 0.94551400 |
| 64 | DMPK | 0.90981665 |
| 65 | CAMK1D | 0.89337261 |
| 66 | PRKCQ | 0.89242414 |
| 67 | LRRK2 | 0.84585420 |
| 68 | YES1 | 0.83883746 |
| 69 | EPHA2 | 0.83148013 |
| 70 | PRKAA2 | 0.82783614 |
| 71 | MAPK11 | 0.80707536 |
| 72 | BMPR2 | 0.79461105 |
| 73 | TAOK1 | 0.79222308 |
| 74 | PDPK1 | 0.78785777 |
| 75 | LCK | 0.78508691 |
| 76 | MAPK12 | 0.78332500 |
| 77 | PRKCH | 0.78083884 |
| 78 | TAOK2 | 0.77741451 |
| 79 | MST1R | 0.76566784 |
| 80 | CAMK1G | 0.76513073 |
| 81 | PINK1 | 0.75307902 |
| 82 | EEF2K | 0.74594291 |
| 83 | CHUK | 0.74274135 |
| 84 | CSK | 0.74044205 |
| 85 | HCK | 0.73539366 |
| 86 | BTK | 0.73462066 |
| 87 | MAP3K2 | 0.71679675 |
| 88 | BCKDK | 0.70894816 |
| 89 | TRPM7 | 0.68798468 |
| 90 | EPHB1 | 0.68526267 |
| 91 | CDC42BPA | 0.68023354 |
| 92 | MAP3K3 | 0.67806133 |
| 93 | BMX | 0.67753663 |
| 94 | PIK3CG | 0.67670013 |
| 95 | CDK7 | 0.67647015 |
| 96 | HIPK2 | 0.67087581 |
| 97 | STK11 | 0.66408466 |
| 98 | CAMKK2 | 0.66162935 |
| 99 | SGK1 | 0.65801776 |
| 100 | MELK | 0.65041525 |
| 101 | MAPK7 | 0.64701254 |
| 102 | PIK3CA | 0.64097090 |
| 103 | BLK | 0.63091567 |
| 104 | SGK2 | 0.62881855 |
| 105 | IRAK1 | 0.62003393 |
| 106 | KSR1 | 0.61742731 |
| 107 | STK24 | 0.61244643 |
| 108 | WNK1 | 0.60900436 |
| 109 | PDGFRB | 0.59185423 |
| 110 | FGR | 0.55771180 |
| 111 | MAP3K9 | 0.54751147 |
| 112 | NEK6 | 0.53555934 |
| 113 | NEK9 | 0.52035974 |
| 114 | STK38 | 0.52019436 |
| 115 | STK10 | 0.51790476 |
| 116 | MAP3K8 | 0.51776001 |
| 117 | MAP3K6 | 0.51501065 |
| 118 | MINK1 | 0.50991064 |
| 119 | CDK4 | 0.50163842 |
| 120 | TEC | 0.50078556 |
| 121 | CDK5 | 0.47438478 |
| 122 | KSR2 | 0.46773401 |
| 123 | MAP2K6 | 0.45105891 |
| 124 | MAPK4 | 0.44891793 |
| 125 | MAP3K1 | 0.44539579 |
| 126 | TYRO3 | 0.43744171 |
| 127 | MAP3K5 | 0.43465457 |
| 128 | RPS6KA2 | 0.42957900 |
| 129 | RPS6KB1 | 0.41123752 |
| 130 | MAPK10 | 0.40132196 |
| 131 | RPS6KA4 | 0.40054204 |
| 132 | RAF1 | 0.39422460 |
| 133 | RPS6KC1 | 0.37220072 |
| 134 | RPS6KL1 | 0.37220072 |
| 135 | MET | 0.37056636 |
| 136 | MAP2K2 | 0.35270611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50219974 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43036520 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83719377 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.47102947 |
| 5 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.88006256 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86703890 |
| 7 | Endometrial cancer_Homo sapiens_hsa05213 | 1.83288055 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69250201 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69180605 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 1.68871930 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 1.49199393 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49027375 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46440065 |
| 14 | Prostate cancer_Homo sapiens_hsa05215 | 1.43783765 |
| 15 | Colorectal cancer_Homo sapiens_hsa05210 | 1.43036800 |
| 16 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.41556323 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39977310 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39375952 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.36969185 |
| 20 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.36731053 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33804369 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.28851945 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28442230 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28049603 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23072822 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17236890 |
| 27 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.16915655 |
| 28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16907855 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16071339 |
| 30 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.16051890 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.15031444 |
| 32 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.14857481 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.12349868 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09507132 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07953256 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07754386 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.04047319 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03839503 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03675935 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03622850 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03396693 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03361047 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03170594 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.02474172 |
| 45 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.02358213 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02268495 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01639472 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01571459 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01406043 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.01054016 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00242556 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00006424 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.99772915 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.99397488 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99337695 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99293401 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98743189 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.98705413 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95139491 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94044726 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92895424 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.92726644 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91981584 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89411857 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88786857 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87521859 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87132887 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86741887 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85834442 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83006820 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.82863118 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82027085 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81385106 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81360409 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78997647 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.77503964 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.77244521 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77188242 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75136753 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74780414 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74307472 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.73244168 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72905596 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72329520 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72325575 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72080039 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72072152 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71890758 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.71455372 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.71402162 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70765374 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70717955 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70563454 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70544135 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69631359 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69367519 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.68864572 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.68154105 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.67634978 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.67540602 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67532908 |
| 102 | Cell cycle_Homo sapiens_hsa04110 | 0.67108474 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66795351 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65725132 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65689966 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65060279 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64732861 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.64016700 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63822572 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62075497 |
| 111 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62048929 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61813594 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60997716 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59825614 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59816473 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59305264 |
| 117 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58891531 |
| 118 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57785828 |
| 119 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57747836 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57001903 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55435589 |
| 122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55159642 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54928982 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54040694 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53997022 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53676811 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.53666180 |
| 128 | Morphine addiction_Homo sapiens_hsa05032 | 0.53380820 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53343206 |
| 130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51170807 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51025467 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50670111 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50526744 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49401070 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49261133 |
| 136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48498215 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48312585 |
| 138 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48092557 |
| 139 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48090474 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47185506 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46887156 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.46619271 |
| 143 | Salivary secretion_Homo sapiens_hsa04970 | 0.46420865 |
| 144 | Hepatitis B_Homo sapiens_hsa05161 | 0.46010416 |
| 145 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44710212 |
| 146 | Influenza A_Homo sapiens_hsa05164 | 0.43668025 |
| 147 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43325902 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42989731 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42411709 |
| 150 | Allograft rejection_Homo sapiens_hsa05330 | 0.42148126 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41480036 |
| 152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41465832 |

